Alzheimers Disease: Targets For Drug Development

Author(s): Andrew J. Larner

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 2 , Issue 1 , 2002

Become EABM
Become Reviewer
Call for Editor


The numerous advances in the understanding of the neurobiology of Alzheimers disease in the past 15 years have suggested many new potential targets for therapeutic intervention. This article gives a broad overview of the spectrum of targets for AD treatment, with particular emphasis on amyloid β-peptides and tau protein.

Keywords: Alzheimers Disease, Amyloid Plaques, Tau Phosphorylation Inhibitors, Tau Aggregation Blockers, GLIAL CELLS

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2002
Page: [1 - 9]
Pages: 9
DOI: 10.2174/1389557023406593

Article Metrics

PDF: 16